RILUTEK
RILUTEK
Approved
DIN Number
02242763
Drug Class
Human
Market Date
Oct 26, 2000
Company
HC
sanofi-aventis canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02242763
AIG Number0141861001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N07XX02 RILUZOLE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:44.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
RILUZOLEActive
Strength: 50 MG
Monograph: RILUZOLE